These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 20818158

  • 41. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Tan SM, Li F, Rajendran P, Kumar AP, Hui KM, Sethi G.
    J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Acacetin Inhibits Cell Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma Cell Lines.
    Alfwuaires M, Elsawy H, Sedky A.
    Molecules; 2022 Aug 23; 27(17):. PubMed ID: 36080130
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
    Tan ZB, Fan HJ, Wu YT, Xie LP, Bi YM, Xu HL, Chen HM, Li J, Liu B, Zhou YC.
    J Ethnopharmacol; 2019 Mar 25; 232():62-72. PubMed ID: 30553869
    [Abstract] [Full Text] [Related]

  • 46. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway.
    Wang J, Lu L, Luo Z, Li W, Lu Y, Tang Q, Pu J.
    Biomed Pharmacother; 2019 Dec 25; 120():109551. PubMed ID: 31648164
    [Abstract] [Full Text] [Related]

  • 47. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.
    Lin L, Fuchs J, Li C, Olson V, Bekaii-Saab T, Lin J.
    Biochem Biophys Res Commun; 2011 Dec 16; 416(3-4):246-51. PubMed ID: 22074823
    [Abstract] [Full Text] [Related]

  • 48. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
    Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, Tai WT, Shiau CW.
    Cancer Lett; 2012 Aug 01; 321(1):27-35. PubMed ID: 22465052
    [Abstract] [Full Text] [Related]

  • 49. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC.
    Liu Y, Liu L, Zhou Y, Zhou P, Yan Q, Chen X, Ding S, Zhu F.
    Clin Cancer Res; 2019 Jul 01; 25(13):4141-4154. PubMed ID: 30918019
    [Abstract] [Full Text] [Related]

  • 50. Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression.
    Hong Y, Zhou L, Xie H, Wang W, Zheng S.
    Biochem Biophys Res Commun; 2015 Jun 05; 461(3):513-8. PubMed ID: 25899746
    [Abstract] [Full Text] [Related]

  • 51. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
    Gong QZ, Xiao D, Gong GY, Xu J, Wen XD, Feng F, Qu W.
    Curr Cancer Drug Targets; 2019 Jun 05; 19(7):583-593. PubMed ID: 30585547
    [Abstract] [Full Text] [Related]

  • 52. Vaccinia virus expressing IL-37 promotes antitumor immune responses in hepatocellular carcinoma.
    Zhang Z, Zhang J, Zhang Y, Xing J, Yu Z.
    Cell Biochem Funct; 2019 Dec 05; 37(8):618-624. PubMed ID: 31710117
    [Abstract] [Full Text] [Related]

  • 53. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L, Yang W, Wu F, Wang C, Yu L, Tang L, Qiu B, Li Y, Guo L, Wu M, Feng G, Zou D, Wang H.
    Clin Cancer Res; 2013 Oct 01; 19(19):5372-80. PubMed ID: 23942093
    [Abstract] [Full Text] [Related]

  • 54. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST, Ho HJ, Lin JT, Shieh JJ, Wu CY.
    Cell Death Dis; 2017 Feb 23; 8(2):e2626. PubMed ID: 28230855
    [Abstract] [Full Text] [Related]

  • 55. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L, Xiao H, Liao R, Chen Q, Peng C, Zhang Y, Mu T, Wu Z.
    Biomed Pharmacother; 2018 Oct 23; 106():68-76. PubMed ID: 29957468
    [Abstract] [Full Text] [Related]

  • 56. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.
    Mano Y, Aishima S, Fujita N, Tanaka Y, Kubo Y, Motomura T, Taketomi A, Shirabe K, Maehara Y, Oda Y.
    Pathobiology; 2013 Oct 23; 80(3):146-54. PubMed ID: 23364389
    [Abstract] [Full Text] [Related]

  • 57. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
    Sui Q, Zhang J, Sun X, Zhang C, Han Q, Tian Z.
    J Immunol; 2014 Aug 15; 193(4):2016-23. PubMed ID: 25015826
    [Abstract] [Full Text] [Related]

  • 58. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J, Lin W, Cao Z, Liu L, Zhuang Q, Zhong X, Hong Z, Peng J.
    Oncol Rep; 2013 Sep 15; 30(3):1309-14. PubMed ID: 23828071
    [Abstract] [Full Text] [Related]

  • 59. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells.
    Li F, Fernandez PP, Rajendran P, Hui KM, Sethi G.
    Cancer Lett; 2010 Jun 28; 292(2):197-207. PubMed ID: 20053498
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.